Monday, November 9, 2026 | Greenville, South Carolina – Industrial Project Innovation (IPI) is pleased to announce that Michael Hildebrand has joined the company as Pharma Business Unit Lead.
Hildebrand brings more than 30 years of experience in capital project management, engineering, manufacturing and operations, with extensive experience in the pharmaceutical industry. His career includes nearly two decades with Eli Lilly, where he held senior leadership roles across capital projects, engineering, operations and pharmaceutical process technology. Most recently, he served as Senior Vice President of Product Delivery for North America at Prime Data Centers, following his role as Project Leader at Tesla.
“Michael brings a tremendous amount of experience leading complex capital projects and technical teams,” said Russ Braasch, Owner, Director. “We are excited to welcome him to IPI and look forward to the expertise and leadership he will bring to our team.”
In his new role, Hildebrand will serve IPI’s pharmaceutical clients while focusing on relationship development, new opportunities and delivering IPI’s services to the industry.
###
About IPI
IPI is an owner’s project management (OPM) firm that provides planning and construction management expertise to clients throughout the program life cycle from concept through operations. Our teammates have extensive backgrounds in strategic and detailed planning, procurement, construction execution, start-up, and maintenance of complex projects and facilities, both domestically and internationally. Our mission is to provide high-value support to our clients through proactive leadership in all phases of a construction program or project. Over the years, IPI has received notable accolades including #1 Fastest Growing Company in South Carolina, #46 CM/PM For-Fee Firm by ENR, #32 Construction Management Firms by ENR, Inc.’s Best Places to Work, and more.
Learn more at ipi.build
